Affect Regulation Training for Pregnant Smokers

Summary

Recent data indicate that approximately one-third of women of childbearing age smoke
cigarettes, and 25-50% of women smoke during pregnancy. Cigarette smoking during pregnancy
is a significant public health issue that can have profound effects on women's health and
the health of their developing fetus. Smoking among pregnant women is associated with high
levels of negative affect, which play a key role in the maintenance of smoking behavior and
in difficulty quitting smoking during pregnancy. Despite the clear role of negative affect
in the maintenance of smoking among pregnant women, and while this issue has received
increased attention by clinicians and researchers, the investigators know of no smoking
cessation intervention that combines coping skills and emotion regulation approaches to
address the role of negative affect in smoking cessation. Smoking cessation treatment
strategies that have demonstrated effectiveness in regular smokers have not translated into
effective treatment strategies for pregnant women, particularly low-income pregnant women.
The goal of this project is to develop and test an affect regulation smoking cessation
intervention for low-income pregnant smokers.

The major aims of this project will be addressed in two sequential phases. In Phase 1, the
investigators will develop two 8-session smoking cessation treatment manuals including: (a)
Affect Regulation Training plus Cognitive-Behavioral Treatment (ART+CBT) and (b) a Health
and Lifestyle plus Cognitive-Behavioral Treatment (HLS+CBT) control intervention. In Phase
2, the investigators will conduct a randomized clinical trial pilot study (Total N = 60) to
compare the ART+CBT and HLS+CBT conditions on: a) the feasibility and acceptability of the
interventions, (b) the impact of these interventions (ART+CBT and HLS+CBT) on smoking
cessation rates at the end of the 8 treatment sessions (these occur approximately 2 months
after treatment initiation) and at the 6-month post-quit date assessment (Session 2 is the
quit date), (c) affect regulation skills, and (d) negative affect among pregnant smokers.
The long-term goal of this proposed research is to increase smoking cessation rates among
pregnant smokers, which would provide significant long-term health benefits for both mothers
and their infants. This Stage 1 application will be used to generate feasibility and
preliminary efficacy data, setting the stage for a Stage II efficacy trial.

Financial incentives are potentially useful tools to aid smoking cessation, but robust evidence to support their efficacy, particularly in combination with other interventions (eg, group counselling),...

Approximately 15% of US women currently smoke during pregnancy. An important step toward providing effective smoking cessation interventions during pregnancy is to identify individuals who are more li...

Despite reductions in cigarette smoking in the U.S., improvements in the efficacy of smoking cessation treatments are needed, as rates of sustained abstinence remain disappointingly low. Both low posi...

Adults with alcohol dependence (AD) have exceptionally high smoking rates and poor smoking cessation outcomes. Discovery of factors that predict reduced smoking among AD smokers may help improve treat...

Medical and Biotech [MESH] Definitions

Smoking Reduction

A decrease in the incidence and frequency of SMOKING. Smoking reduction differs from SMOKING CESSATION in that the smoker continues to smoke albeit at a lesser frequency without quitting.

Smoking Cessation

Discontinuation of the habit of smoking, the inhaling and exhaling of tobacco smoke.

Tobacco Use Cessation

Cessation of the habit of using tobacco products for smoking or chewing, including the use of snuff.

Area Health Education Centers

Education centers authorized by the Comprehensive Health Manpower Training Act, 1971, for the training of health personnel in areas where health needs are the greatest. May be used for centers other than those established by the United States act.

Varenicline

A benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.

More From BioPortfolio on "Affect Regulation Training for Pregnant Smokers"

Relevant Topics

Obstetrics and gynaecologyFertility
Menopause
Obstetrics & Gynaecology
Osteoporosis
Women's Health
Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...